Popular Articles From: European Commission Approves Huntsman's Acquisition Of Rockwood's Performance Additives And Titanium Dioxide Businesses to Inland Real Estate Corporation Pays September and Declares October Cash Distribution to Common Stockholders


Huron Consulting Group (NASDAQ: HURN), a leading provider of business consulting services, today announced that it has been named a Top Workplace by The Oregonian for the second consecutive year.
Sign-up for Huron Consulting Group Named a 2014 Top Workplace by The Oregonian investment picks
Huron Consulting Group Inc. (NASDAQ:HURN), a leading provider of business consulting services, today announced the pricing of $225 million aggregate principal amount of convertible senior notes due 2019 (the "Convertible Notes"). The Convertible Notes were offered in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The Company granted an option to the initial purchasers to purchase, within a period of 13 days beginning on, and including, the date the Convertible Notes are first issued, up to an additional $25 million aggregate principal amount of Convertible Notes.
Sign-up for Huron Consulting Group Prices Private Offering of $225 Million of Convertible Senior Notes Due 2019 investment picks
BRISBANE, Calif., June 25, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the European Medicines Agency (EMA) has completed technical and content validation and accepted the filing of the Marketing Authorisation Application (MAA) for RAVICTI (glycerol phenylbutyrate) Oral Liquid for the treatment of urea cycle disorders (UCDs). Acceptance of the MAA confirms that the submission is complete so as to permit a substantive review by the Rapporteurs and the Committee for Medicinal Products for Human Use (CHMP). "We are very pleased to receive MAA acceptance for review of RAVICTI and anticipate a CHMP opinion in the third quarter of 2015," said Donald J.
Sign-up for Hyperion Therapeutics Announces EMA Acceptance for Review of Marketing Authorization Application for RAVICTI(R) investment picks
First Watson Consumer Facing Application Available to USAA Members ARMONK , N.Y. and SAN ANTONIO , July 23, 2014 /PRNewswire/ -- IBM (NYSE: IBM ) and USAA announced that the cognitive capabilities of IBM Watson technology are now available to USAA members.
Sign-up for USAA and IBM Join Forces to Serve Military Members investment picks
New chip with brain-inspired non-von Neumann computer architecture has one million neurons and 256 million synapses Built on Samsung's 28nm process technology, the 5.4 billion transistors chip has an on-chip network of 4096 neurosynaptic cores but only consumes 70mW during real-time operation Complete cognitive hardware and software ecosystem opens new computing frontier for mobile, cloud, supercomputing and distributed sensor applications SAN JOSE, Calif.
Sign-up for New IBM SyNAPSE Chip Could Open Era of Vast Neural Networks investment picks
The beginning of a transition from e-Government to m-Government ZAGREB, Croatia , Sept.
Sign-up for Croatia Builds New Mobile Government on IBM Mainframe - citizens can now access critical services in just minutes investment picks
Fast-growing bank inks 5-year deal with IBM for IT management services in West Africa ACCRA, Ghana and WASHINGTON , Aug.
Sign-up for At U.S. - Africa Business Forum, Ghana's Fidelity Bank Chooses IBM to Drive Transformation Agenda investment picks
New cloud-based service delivers near-real time HD content to global sports fans ARMONK, N.Y. , Sept.
Sign-up for Aspera, an IBM Company, Partners with EVS and Elemental to Bring Unprecedented Second Screen Video Streaming to Millions of Sports Fans Worldwide investment picks
Actua to Trade on the NASDAQ Under Ticker Symbol ACTA RADNOR, Pa., Sept.
Sign-up for ICG Changes Name to Actua, Reflecting Evolution to a Multi-Vertical Cloud Company investment picks
By Jennifer Booton, MarketWatch NEW YORK (MarketWatch) -- Jennifer Lawrence's bottom might be blasted out for the world to see, but don't expect people to shy away from cloud computing or Apple products in general.
Sign-up for Celeb nude photos won't hurt the cloud investment picks
RALEIGH, N.C., Aug.
Sign-up for Icon Media Holdings, Inc. Opens MMJ-X.COM for Beta investment picks
BOISE, Idaho , Sept.
Sign-up for IDACORP Increases Quarterly Common Stock Dividend 9.3 Percent investment picks
http://media.marketwire.com/attachments/201311/207012_jpg_IPC_Logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1143512&ProfileId=051205&sourceType=1 AUSTIN, TX --
Sign-up for Ideal Power Appoints Industry Veteran Ryan O'Keefe as Senior Vice President, Business Development investment picks
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing nucleic acid therapeutics for rare diseases, today reported financial and operational results for the quarter ended June 30, 2014.
Sign-up for Idera Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Corporate Update investment picks
WINDERMERE, Fla.
Sign-up for iMedicor Signs Relationship with Florence-Darlington Technical College investment picks
SEATTLE and SOUTH SAN FRANCISCO, Calif., July 29, 2014 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ) announced today the closing of its initial public offering of 5,000,000 shares, at a public offering price of $12.00 per share, resulting in aggregate gross proceeds of $60.0 million, before underwriting discounts, commissions and expenses.
Sign-up for Immune Design Announces Closing of Initial Public Offering investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961044001&sourceType=1 http://media3.marketwire.com/logos/20121102-iiinew.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Imperial Update on Tailings Storage Facility Breach at Mount Polley Mine investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0966234001&sourceType=1 http://media3.marketwire.com/logos/20121102-iiinew.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Imperial Completes $115 Million Non-Brokered Private Placement of Convertible Debentures investment picks
WILMINGTON, Mass.
Sign-up for Implant Sciences Responds to Levi & Korsinsky, LLP Press Release /Solicitation investment picks
Luxoft Holding, Inc (NYSE:LXFT), a leading provider of software development services and innovative IT solutions to a global client base, today announced that IBS Group Holding Limited (“IBS Group”), the controlling shareholder of Luxoft Holding, Inc (“Luxoft” or the “Company”) announced its intent to propose a reorganization of IBS Group via an exchange of shares and Global Depository Receipts (“GDRs”) in IBS Group for shares of Luxoft through a scheme of arrangement (the “Scheme”). According to IBS Group’s announcement, pursuant to the proposed Scheme, global depositary receipts of IBS Group and issued and outstanding shares of IBS Group, other than the shares held by BXA Investments Ltd (“BXA”) and Croyton Limited (“Croyton”), (together, the “Scheme Securities”) will be cancelled and class B shares of the Company will be transferred to the holders of the Scheme Securities in
Sign-up for Luxoft Holding Announces a Proposed Reorganization of its Majority Shareholder, IBS Group Holding, Involving an Exchange of a Portion of IBS Group's Share Capital for a Portion of its Shares in Luxoft investment picks
Schubert Jonckheer & Kolbe LLP Investigates Case Against the Company's Top Executives SAN FRANCISCO , Sep.
Sign-up for ESI Shareholder Alert: Do You Own Stock in ITT Educational Services? investment picks
Advisory services team reimagines the branch experience for downtown Albany, N.Y., location NORTH CANTON, Ohio , Sept.
Sign-up for Diebold Guides Branch Transformation Journey For Kinderhook investment picks
Incyte Corporation (Nasdaq: INCY) today reported 2014 second-quarter financial results, including revenue from Jakafi ® (ruxolitinib), which is approved by the U.S. Food & Drug Administration (FDA) for the treatment of patients with intermediate or high-risk myelofibrosis (MF). The Company highlighted its strong financial position, driven by growing Jakafi sales in the U.S. and Jakavi ® (ruxolitinib) royalties outside the U.S., as well as the submission of the ruxolitinib supplemental New Drug Application (sNDA) in the U.S. for patients with uncontrolled polycythemia vera (PV). The Company also discussed its expanding clinical pipeline, which includes pivotal as well as proof of concept studies, and the multiple data presentations for the Company’s product candidates that were made at the recent American Society of Clinical Oncology (ASCO) meeting.
Sign-up for Incyte Reports 2014 Second-Quarter Financial Results and Updates Shareholders on Key Clinical Programs investment picks
Incyte Corporation (Nasdaq:INCY) announced today that the U.S. Food & Drug Administration (FDA) has approved supplemental labeling for Jakafi ® (ruxolitinib) to include new Kaplan-Meier overall survival curves as well as additional safety and dosing information.
Sign-up for Jakafi® (ruxolitinib) Product Label Expanded to Include Overall Survival Data and Additional Safety and Dosing Information investment picks
Incyte Corporation (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the supplemental New Drug Application (sNDA) for ruxolitinib as a potential treatment of patients with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea.
Sign-up for FDA Accepts Supplemental New Drug Application for Jakafi® (ruxolitinib) and Priority Review Granted investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the BMO Capital Markets 3 rd Annual Biotech Corporate Access Day on July 29, 2014.
Sign-up for Infinity to Participate in the BMO Capital Markets 3RD Annual Biotech Corporate Access Day investment picks
SAN DIEGO , Sept.
Sign-up for InfoSonics Reveals Its First LTE Smartphone: the verykool® SL5000 'Quantum' investment picks
Inland Real Estate Corporation (NYSE: IRC) today announced that it paid a cash distribution of $0.0475 per share on the outstanding shares of its common stock to common stockholders of record at the close of business on September 2, 2014.
Sign-up for Inland Real Estate Corporation Pays September and Declares October Cash Distribution to Common Stockholders investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Popular Articles From: European Commission Approves Huntsman's Acquisition Of Rockwood's Performance Additives And Titanium Dioxide Businesses to Inland Real Estate Corporation Pays September and Declares October Cash Distribution to Common Stockholders
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices